Medicis Pharmaceutical Corp.’s (MRX) share price has entered into oversold territory with a stochastic value of 7.666. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 2 cents over the past month to $2.77 per share. Medicis Pharmaceutical Corp. is a Zacks #2 Rank (“Buy”) company.
MEDICIS PHARM-A (MRX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment